Daily Cosmetic Research Analysis
Analyzed 35 papers and selected 3 impactful papers.
Summary
Three impactful studies at the cosmetics–health interface stood out today: a mouse study linking propylparaben exposure to preeclampsia-like phenotypes via FDX1 downregulation; mechanistic evidence that salicylate UV filters trigger pyroptosis and necroptosis; and a bioengineered, hydroxylated recombinant human type III collagen fused to a transdermal peptide achieving markedly enhanced skin penetration and repair in preclinical models.
Research Themes
- Cosmetic ingredient safety and mechanistic toxicology
- Safer-by-design approaches for UV filters and preservatives
- Bioengineered dermal biomaterials for skin repair and aesthetics
Selected Articles
1. Propylparaben Exposure May Impair Uterine Decidualization via FDX1 Downregulation and Induce Preeclampsia-like Symptoms in Mice.
In a pregnant mouse model, continuous propylparaben exposure produced preeclampsia-like hypertension and proteinuria, with impaired decidualization and reduced multinucleated decidual cells. Transcriptomics revealed FDX1 downregulation, suggesting disruption of steroidogenesis and receptor signaling as a mechanistic basis.
Impact: This study links a widely used cosmetic preservative to pregnancy complications via a defined molecular pathway, informing risk assessment and regulatory considerations. It provides mechanistic evidence bridging environmental exposure and reproductive outcomes.
Clinical Implications: Advise precautionary minimization of paraben exposure during pregnancy and consider biomonitoring in high-risk populations while human studies are pursued. Findings may prompt re-evaluation of allowable exposure limits for propylparaben.
Key Findings
- Continuous propylparaben exposure in pregnant mice induced hypertension and proteinuria consistent with preeclampsia-like symptoms.
- Uterine decidualization was impaired with a significant reduction in multinucleated decidual cells.
- RNA-seq of deciduomas showed downregulation of FDX1, implying disrupted steroidogenesis and altered estrogen/progesterone receptor target gene expression.
Methodological Strengths
- In vivo pregnancy model with phenotypic endpoints (blood pressure, proteinuria) relevant to preeclampsia.
- Transcriptomic analysis linking phenotype to a specific molecular pathway (FDX1).
Limitations
- Findings are limited to a mouse model; human translational relevance requires epidemiologic and clinical validation.
- Exposure levels and routes in mice may not mirror real-world human exposure patterns.
Future Directions: Prioritize human biomonitoring and pregnancy cohort studies examining PP exposure, FDX1 pathway perturbations, and hypertensive disorders; assess dose–response and safer preservative alternatives.
Preeclampsia (PE) is a pregnancy-specific disorder that poses a significant threat to maternal and fetal health. Its pathogenesis is regulated by multiple factors, including genetic and environmental cues, but the specific underlying mechanisms remain incompletely elucidated. Propylparaben (PP) is a widely used additive in daily products such as cosmetics and food. Previous studies have confirmed that excessive PP exposure exerts adverse effects on the reproductive system. To clarify the potential impact of PP exposure on pregnancy outcomes, this study established a continuous PP exposure model in pregnant mice. Results showed that pregnant mice in the PP group exhibited typical PE-like symptoms-hypertension and proteinuria. Concurrently, the number of multinucleated cells in uterine decidua was significantly reduced, with marked impairment of the decidualization process. To further explore the molecular mechanisms, RNA transcriptome sequencing was performed on artificially induced deciduomas. PP exposure significantly downregulated the expression of ferredoxin 1 (FDX1). Reduced FDX1 expression may decrease estrogen and progesterone levels in mice, and disrupt the normal expression of estrogen/progesterone receptors and their target genes. In summary, this study demonstrates that PP exposure may impair uterine decidualization and disturb normal placental development by inhibiting FDX1 expression, thereby inducing PE-like symptoms in pregnant mice.
2. Development of a novel hydroxylated recombinant human type III collagen TD-1-HrHC in Komagataella phaffii with transdermal and skin damage repair activity.
A hydroxylated recombinant human type III collagen fused with the TD-1 transdermal peptide (TD-1-HrHC) showed a 20-fold-plus increase in transdermal delivery versus native collagen, enhanced barrier/differentiation factor expression in keratinocytes, and improved skin repair with neocollagenesis in mice.
Impact: Demonstrates a practical bioengineering strategy to overcome the skin barrier for macromolecules, with direct relevance to dermocosmetics and post-procedure recovery products.
Clinical Implications: Supports development of more efficacious topical collagen-based formulations for barrier repair and rejuvenation; clinical trials are needed to confirm efficacy, dosing, and safety in humans.
Key Findings
- TD-1-HrHC achieved approximately 11.89% hydroxylation, comparable to natural human collagen III.
- Transwell assays showed a 2077% increase in transdermal efficiency versus native animal-derived collagen III.
- Promoted skin repair by modulating barrier and differentiation factors in HaCaT cells and induced neocollagenesis in a mouse skin damage model.
- Inhibited protein carbonylation in HaCaT cells, suggesting protection against oxidative protein damage.
Methodological Strengths
- Combines protein engineering, biochemical characterization, in vitro functional assays, and in vivo efficacy testing.
- Quantitative transdermal assessment with benchmark comparison to native collagen.
Limitations
- Lacks human clinical data on efficacy, tolerability, and long-term safety (e.g., immunogenicity).
- Formulation stability and large-scale manufacturability in finished products were not addressed.
Future Directions: Conduct dose-ranging human patch penetration and early-phase clinical studies; evaluate safety/immunogenicity, durability of effect, and synergy with standard skincare actives.
BACKGROUND: Collagen has been proven to have significant potential applications value in the fields of on medical aesthetics and cosmetics. However, due to its large molecular weight, collagen is difficult to effectively penetrate the skin barrier and reach the designated location to exert the expected activities. Transdermal peptide TD-1 is a short peptide consisting of only 11 amino acids, which can assist proteins such as insulin and cytokines to penetrate the skin barrier and reach the dermis layer. To maximize the transdermal and the efficacy of Collagen III in skincare, the shortest functional fragment that containing a triple helix structure of collagen protein fused with TD-1 were designed and evaluated for its transdermal activity, safety and efficacy. RESULTS: The recombinant protein containing transdermal TD-1 fragment and a core active fragment of human collagen III (TD-1-HrHC) was co-expressed together with specific hydroxylase using the K. phaffii expression system, the products were purified by hydrophobic interaction chromatography (HIC) and ion-exchange chromatography (IEC). The TD-1-HrHC contains about 11.89% hydroxylation modifications that are similar to the natural human collagen III. The transdermal efficiency is 2077% measured by trans-well tests compare to the nature Collagen III isolated from animals. In addition, TD-1-HrHC able to promotes skin damage repairing through regulation series of barrier factors and differentiation factors in the HaCat cell model and promotes the repair of damaged skin and induces the generation of new-born collagen in mouse model. Moreover, it also shown an excellent ability to inhibit protein carbonylation on HaCat cells. CONCLUSION: This study demonstrates that TD-1-HrHC can effectively cross the skin barrier and has profound ability to inhibit protein carbonylation of skin and promote skin damage repairing.
3. Pyroptosis- and Necroptosis-Related Signaling in Salicylate UV Absorber-Induced Toxicity: Implications for Sustainable Chemistry and Human Health.
Salicylate-type UV filters (EHS and HMS) triggered oxidative stress, calcium dysregulation, mitochondrial injury, and DNA damage, with molecular evidence for concurrent activation of pyroptosis and necroptosis in mammalian cells, corroborated by zebrafish in vivo toxicity. These mechanisms inform safer-by-design UV filter development and risk assessment.
Impact: Reveals dual regulated cell death pathways in cosmetic UV filter toxicity, advancing mechanistic understanding crucial for human health protection and sustainable formulation strategies.
Clinical Implications: Supports precautionary evaluation of salicylate UV filters and prioritization of alternatives with lower propensity to induce pyroptosis/necroptosis; informs regulatory toxicology and post-market surveillance.
Key Findings
- EHS and HMS caused oxidative stress, intracellular Ca2+ dysregulation, mitochondrial impairment, and DNA damage in mouse embryonic fibroblasts.
- Molecular analyses suggested concurrent activation of pyroptosis and necroptosis as regulated cell death pathways.
- Zebrafish models corroborated in vivo toxicological phenotypes of salicylate UV absorbers.
Methodological Strengths
- Use of both mammalian cell culture and zebrafish models to bridge in vitro and in vivo evidence.
- Multi-parametric assessment capturing oxidative stress, calcium homeostasis, mitochondrial function, and DNA damage.
Limitations
- Specific molecular markers for pyroptosis/necroptosis are not detailed in the abstract; mechanistic depth in vivo remains to be expanded.
- Human exposure relevance (doses, mixtures, chronicity) requires further study.
Future Directions: Benchmark salicylate filters against alternative UV filters using standardized toxicogenomic and cell-death assays; perform realistic exposure models and mixture toxicology; integrate data into regulatory safety assessments.
As emerging global environmental contaminants, organic ultraviolet absorbers (OUVAs) are widely used in personal care formulations and exhibit environmental persistence and potential bioaccumulation. Among these compounds, 2-ethylhexyl salicylate (EHS) and homosalate (HMS) are the most frequently used salicylate-type UV filters in cosmetic formulations. Although an increasing number of studies have demonstrated their environmental hazards, little is known about the molecular mechanisms underlying their cytotoxicity in mammalian systems, a fundamental knowledge gap for both human health protection and the development of more environmentally friendly consumer goods. In this study, we used mouse embryonic fibroblasts (MEFs, 3T6) and zebrafish as models to assess the toxicological phenotypes of EHS and HMS in vitro and in vivo, respectively. We found that both EHS and HMS induced cellular damage characterized by oxidative stress, disrupted intracellular calcium homeostasis, mitochondrial impairment, and DNA damage. Importantly, molecular analyses further suggested the concurrent activation of two distinct regulated cell death programs: pyroptosis, as suggested by